Blood Stream Infection Testing Market Forecast and Analysis: Key Insights into Growth, Trends, and Emerging Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Forecasted Expansion Rate of the Blood Stream Infection Testing Market Over the 2025–2034 Period?
The market size for blood stream infection testing has experienced substantial growth lately. It is projected to escalate from $7.59 billion in 2024 to $8.49 billion in 2025, showing a compound annual growth rate (CAGR) of 11.9%. The growth observed during the historic period can be credited to factors such as growing prevalence of hospital-acquired infections, a rise in antimicrobial resistance, an increase in the elderly population, escalating healthcare expenditure, and a surge in chronic disease occurrences.
The market size for blood stream infection testing is anticipated to witness swift expansion in the forthcoming years, with projections indicating a growth to $13.19 billion in 2029, with a compound annual growth rate (CAGR) of 11.7%. The predicted growth during this forecast period is attributed to the escalating demand for rapid diagnostic tests, increased use of molecular diagnostics, growing emphasis on personalized medicine, government measures for infection control, and the rising instance of multi-drug-resistant pathogens. Emerging trends within the forecast period encompass the expanding use of AI in diagnostic tools, merging telemedicine with diagnostic services, increasing demand for home-based testing kits, the creation of multiplex diagnostic platforms, as well as growing collaborations between diagnostic firms and hospitals.
What Industry-Specific Factors Are Fueling the Growth of the Blood Stream Infection Testing Market?
The growing incidence of infectious diseases is anticipated to promote the expansion of the blood stream infection testing market. These diseases, which are induced by harmful microorganisms including bacteria, viruses, fungi, or parasites, have increasing rates due to various reasons such as augmented worldwide travel, urbanization, climate change, resistance to antibiotics, and vaccination coverage gaps. It is vital to conduct blood stream infection tests in case of infectious diseases, as it helps diagnose and determine the pathogens causing severe infections like sepsis, thus facilitating efficient and targeted treatment. For example, the most recent World Malaria report by the World Health Organization (WHO), a United Nations agency based in Switzerland, indicated that the number of malaria cases in 2022 was 249 million, a rise from 244 million in 2021. The estimated death toll from malaria was approximately 608,000 in 2022, slightly lower than the 610,000 in 2021. Hence, due to the rising prevalence of infectious diseases, the blood stream infection testing market is experiencing significant growth.
Request Your Free Blood Stream Infection Testing Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20514&type=smp
Who Are the Leading Organizations Fueling the Expansion of the Blood Stream Infection Testing Market?
Major companies operating in the blood stream infection testing market are:
• Thermo Fisher Scientific Inc._x000D_
• Abbott Laboratories_x000D_
• F. Hoffmann-La Roche Ltd_x000D_
• Danaher Corporation_x000D_
• Siemens Healthcare Private Limited_x000D_
Which Cutting-Edge Trends Are Expected to Drive the Blood Stream Infection Testing Market’s Growth?
Key players in the bloodstream infection testing market are shifting their attention towards creating novel items like blood testing cartridges in order to maintain market dominance. Blood testing cartridges, which are single-use devices used to examine blood samples during diagnostic procedures, are part of this innovation. These cartridges come equipped with pre-included reagents, as well as integrated sensors or microscopic channels, designed to identify certain biomarkers, pathogens, or conditions from a minimal blood sample. In an example from August 2022, Immunexpress Pty Ltd., a molecular diagnostics company based in Australia, introduced their SeptiCyte RAPID cartridges. These cartridges utilize undiluted ethylenediaminetetraacetic acid (EDTA) blood as a verified sample type, proven to correlate well with other methods of blood collection, as evidenced by a multi-site study conducted in Europe. This progress enhances the precision and speed of sepsis diagnosis, paving the way for broader and quicker clinical implementation. This could revolutionize patient care, while at the same time reducing the cost of healthcare.
Secure Your Global Blood Stream Infection Testing Market Report Now for Fast and Efficient Delivery!
What Are the Key Components of the Blood Stream Infection Testing Market, and How Do Its Segments Perform?
The blood stream infection testing market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Sample Type: Whole Blood, Blood Culture
3) By Technology: Polymerase Chain Reaction (PCR), Mass Spectroscopy, In Situ Hybridization, Other Technologies
4) By End-User: Hospitals And Diagnostic Centers, Laboratory Service Providers, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Blood Culture Systems, Automated Microbial Identification Systems, Molecular Diagnostic Instruments
2) By Reagents and Consumables: Blood Culture Media, Antimicrobial Susceptibility Testing Reagents, Nucleic Acid Extraction Kits
3) By Software and Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services
Which Regions Are Most Influential in Expanding the Blood Stream Infection Testing Market?
North America was the largest region in the blood stream infection testing market in 2024. The regions covered in the blood stream infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does the Definition of the Blood Stream Infection Testing Market Include?
Blood stream infection testing involves diagnostic procedures to detect and identify pathogens in the blood, such as bacteria, fungi, or viruses, that cause infections. It typically includes blood cultures and molecular assays to determine the specific microorganism responsible. Accurate and timely testing is crucial for effective treatment and management of sepsis and other serious infections.
Browse Through More Similar Reports By The Business Research Company:
Infection Control Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report
Infection Control Supplies Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report
Urinary Tract Infection Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
